S3 Fig - by R. J. S. D. Heine (17889199)

Subjects:

S6 Fig - by R. J. S. D. Heine (17889199)

Subjects:

CBP per cumulative indication for daratumumab and pembrolizumab per vial. by R. J. S. D. Heine (17889199)

Subjects:

Inputs utilized in base-case and scenario analysis for daratumumab and pembrolizumab, both unadjusted and adjusted for PPP and inflation. by R. J. S. D. Heine (17889199)

Subjects:

Implementation of indication-based pricing (10^th scenario) for daratumumab and pembrolizumab. by R. J. S. D. Heine (17889199)

Subjects:

Scenario analysis for daratumumab using a cumulative cost-based price per year per vial. by R. J. S. D. Heine (17889199)

Subjects:

Input parameters for the base-case analysis. by R. J. S. D. Heine (17889199)

Subjects:

S2 Fig - by R. J. S. D. Heine (17889199)

Subjects:

S1 Data - by R. J. S. D. Heine (17889199)

Subjects:

The interaction effect of O₃ with age. by John Brandt (6880463)

“…We combine high frequency data on ozone and fine particulate pollution with daily consumer spending in brick-and-mortar retail in 129 postal codes in Spain during 2014 to estimate the association between the two. Using a linear fixed effects model, we find that a 1-standard deviation increase in ozone concentration (20.97 μg/m³) is associated with 3.9 percent decrease in consumer spending (95% CI: -0.066, -0.012; p<0.01). …”

Effects of Remote Ischemic Preconditioning on Decreasing Troponin Release in Patients Not Taking Sulfonylureas After Cardiac Surgery – A Meta-Analysis by Xiaotong Wang (276499)

Effects of Remote Ischemic Preconditioning on Decreasing Troponin Release in Patients Not Taking Sulfonylureas After Cardiac Surgery – A Meta-Analysis by Xiaotong Wang (276499)

Model of CRC stage at diagnosis with delays to diagnosis (Australia). by Joachim Worthington (8394213)

Subjects:

Modelled monthly changes in colorectal cancer procedure capacity assumed for Canada, based on data from Ontario (treatments and diagnoses) and from OncoSim (diagnoses of screen-det... by Joachim Worthington (8394213)

Subjects:

Scenarios analysed. by Joachim Worthington (8394213)

Subjects:

A visual summary of the key study findings. by Joachim Worthington (8394213)

Subjects:

Fig 3 - by Joachim Worthington (8394213)

Subjects:

Post- diagnosis CRC survival model (Australia). by Joachim Worthington (8394213)

Subjects:

Model outputs used to inform this study. by Joachim Worthington (8394213)

Subjects:

Fig 4 - by Joachim Worthington (8394213)

Subjects: